http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102697740-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8976e63ccfa14d6ed9b09ba7c17b6c33 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| filingDate | 2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b9d1e9716dc1aa5c39ae383a4e15bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c70e36fcbdb73cd6aad6bd973952d4d |
| publicationDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102697740-B |
| titleOfInvention | Gemcitabine hydrochloride lyophilized powder for injection and preparation method thereof |
| abstract | The invention discloses gemcitabine hydrochloride lyophilized powder for injection. The gemcitabine hydrochloride lyophilized powder consists of the following components in parts by mass: 100 parts of gemcitabine hydrochloride, 160-180 parts of lactose and 3-6 parts of sodium citrate. As proved by influencing factor testing investigation, each detection index the gemcitabine hydrochloride lyophilized powder for injection prepared by adopting a formula and a process provided by the invention does not change remarkably in a high-temperature, high-humidity and strong-light-irradiation environment, and high stability is achieved. |
| priorityDate | 2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.